Well in short term description of Rosy press release looks correct. Stock going back down
Still dropping. Where is price where the optionality of getting a favorable result is compelling 7 bucks per share?Should calls be used instead given risk to downside?
Why is this a pump and dump?. We know they have to sell stock to fund themselves. Isnt flowery press releases par for the course?
No I said sell now and see if you can buy back at 7 and replace with calls. It is ahead of itself. The release was clearly attempting to put a good light on somewhat disappointing data.
However very little improvement in only one category. I guess they have enough to spend millions on a phase three but only can hope for better results. Looks like the biggest piece of positive news out of this data is safety. However that is not enough to stay at 10 buck per share. I was surprised stock even went up but pigs fly in this market and biotech is catching a lot of day traders and retail. I would guess they will be selling into this to raise cash for future trials but they better hope for some good news out of imagine. I would sell let stock go down to 7 or so and look for the volatility to come out of the calls and buy some just before imagine data. Stock is way too risky and way ahead of itself. If imagine data is bad we could see 2 bucks again if the market turns down. Remember the cash burn here will be huge. Good luck.
They should be down. When the company blows up it will be very painful for unsuspecting buyers, Only the investment bankers pumping.
PCO has Contentguard which owns all the patents this stock could get AAPL to buy them (or GOOG) because a win or two in litigation could drive the stock up 100% or much more...